2 unread notifications

Ben Freeberg founded Oncology Ventures, a firm investing in commercially validated startups transforming cancer care. Following their $32M Fund II, in 2026 announced its oversubscribed $62M Fund II. A cancer survivor and stand-up comic, he previously invested in healthcare technology at Optum Ventures and Alpha Partners and helped build Thyme Care, a value-based cancer care company.

Claimed by the subject

Ben Freeberg founded Oncology Ventures, a firm investing in commercially validated startups transforming cancer care. Following their $32M Fund II, in 2026 announced its oversubscribed $62M Fund II. A cancer survivor and stand-up comic, he previously invested in healthcare technology at Optum Ventures and Alpha Partners and helped build Thyme Care, a value-based cancer care company.

Career

Ben Freeberg holds a BSc, Economics from Duke University.

Founder and Managing Partner at Oncology Ventures until Present in New York, NYInvests in commercially validated startups across the cancer care journey, from early detection to survivorship. Writes the Oncology Ventures newsletter on Substack.

Cosigns Received

These Cosigners think Ben will be a star

oncologyventures.substack.com

Announcing Oversubscribed $62M Fund II to Accelerate the Future of Cancer Care

Open ↗
oncologyventures.substack.com

Cancer Care in 2040

Open ↗
oncologyventures.substack.com

What if Cancer Care Operated Like The Ritz-Carlton

Open ↗
oncologyventures.substack.com

A Working Playbook for Funding Cancer Innovation

Open ↗

Ben's Collections

Ben's Lists

In these lists

Cosigns Given